Niche Toxicology Biotap Medical Laboratory specializes in urine and oral toxicology and molecular infectious disease testing, presenting a focused opportunity to upsell ancillary lab services to healthcare systems and medical offices expanding toxicology screening programs.

CAP and CLIA Being CAP accredited and CLIA certified positions Biotap as a trusted partner for high-complexity testing, which can be leveraged in conversations with hospital systems and clinics seeking compliant, high-quality laboratory partners.

Growth-ready Revenue With current revenue in the lower mid-range and a small team, there is potential to scale services through add-on tests, expanded payer adoption, and contract-based relationships with larger health networks seeking regional toxicology and infectious disease testing capacity.

Tech & Compliance Utilizing HIPAA, Availity, and other tech stack tools, Biotap can position itself as a seamless, compliant integration partner for health networks already using these platforms, facilitating data exchange and results delivery.

Targeted Expansion The company’s focus on medical offices and healthcare systems suggests sales opportunities in regional hospitals, clinics, and urgent care networks seeking reliable high-complexity labs, with potential for referral partnerships and managed services arrangements.